LGND
Ligand Pharmaceuticals Incorporated
$161.71
+$1.75(+1.09%)
66
Overall
--
Value
72
Tech
60
Quality
Market Cap
$3.13B
Volume
147.03K
52W Range
$93.58 - $163.34
Target Price
$168.14
Key Metrics Overview
| Market Cap | $3.13B | P/E Ratio | 646.84 |
| 52W High | $163.34 | 52W Low | $93.58 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -20.4% | 52W Position | 97.7% |
| Overall Score | 66 | Value Score | -- |
| Quality Score | 60 | Technical Score | 72 |
Growth Analysis
| EPS Current Est | $0.25 | EPS Next Est | $4.72 |
| EPS Growth Est | +1788.0% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LGND | $161.71 | +1.1% | 147.03K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ligand Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW